United States v. Jeffrey H. Feingold

454 F.3d 1001, 2006 U.S. App. LEXIS 18319, 2006 WL 2035305
CourtCourt of Appeals for the Ninth Circuit
DecidedJuly 21, 2006
Docket05-10037
StatusPublished
Cited by67 cases

This text of 454 F.3d 1001 (United States v. Jeffrey H. Feingold) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Jeffrey H. Feingold, 454 F.3d 1001, 2006 U.S. App. LEXIS 18319, 2006 WL 2035305 (9th Cir. 2006).

Opinion

BETTY B. FLETCHER, Senior Circuit Judge.

Under the Controlled Substances Act (CSA), it is unlawful for “any person” knowingly or intentionally to distribute or dispense a controlled substance. 21 U.S.C. § 841(a). Although the CSA makes exceptions to this prohibition for certain individuals who are registered “practitioners” under the Act, such as physicians and pharmacists, see 21 U.S.C. §§ 821-23, the Supreme Court has held that these practitioners are still subject to criminal prosecution “when their activities fall outside the usual course of professional practice.” United States v. Moore, 423 U.S. 122, 124, 96 S.Ct. 335, 46 L.Ed.2d 333 (1975); see also 21 C.F.R. § 1306.04 (providing that a practitioner “shall be subject to the penalties ... relating to controlled substances” unless the prescriptions he writes are “issued for a legitimate medical purpose ... [and he is] acting in the usual course of his *1004 professional practice”). Thus, a physician remains criminally liable when he ceases to distribute or dispense controlled substances as a medical professional, and acts instead as a “pusher.” Moore, 423 U.S. at 138, 143, 96 S.Ct. 335.

Dr. Jeffrey Feingold, a naturopathic physician licensed by the State of Arizona, was convicted on 185 counts of illegally distributing controlled substances, in violation of 21 U.S.C. § 841(a). He contends that his conviction is constitutionally infirm due to improperly admitted testimony and erroneous jury instructions. The thrust of both of these objections is that the district court permitted the jury to convict him upon finding that he was merely an incompetent doctor, rather than upon the necessary finding that his conduct was so egregious as to render him criminally liable. He also argues that his sentence is invalid because the district court improperly relied on facts not found by the jury and because the district court denied his request for a two-level reduction in his offense level.

Although we hold that Dr. Feingold’s arguments are without merit, we vacate his sentence and remand for resentencing pursuant to United States v. Beng-Salazar, 452 F.3d 1088 (9th Cir.2006).

I.

Dr. Feingold graduated in 1976 from the National College of Naturopathic Medicine and, after completing an internship and residency, began his career in Philadelphia. In 1990, he moved to Arizona, where he later opened his own practice. In 2000, the State of Arizona granted naturopathic physicians authority to prescribe Schedule II, III, IV, and V controlled substances. In August of 2002, Arizona curtailed this authority, prohibiting naturopathic physicians from prescribing Schedule II drugs, with the exception of morphine. Dr. Fein-gold obtained from the Drug Enforcement Agency (DEA) the necessary certification to prescribe controlled substances. The prescriptions written by him pursuant to this certification became the basis for a 185-count indictment. The government alleged that Dr. Feingold abused his status as a licensed practitioner to distribute controlled substances outside the course of his professional practice.

At trial, the government presented evidence from several of Dr. Feingold’s so-called patients. Their testimony against him overwhelmingly demonstrated his disregard for proper prescribing practices. For example, several patients testified that they received prescriptions from Dr. Fein-gold even though he had never physically examined them and even though he never recorded the medical basis for prescribing these controlled substances in his patients’ medical charts. Other patients testified that he had given them controlled substances even though he knew that they were recovering drug addicts. Others testified that they received prescriptions even though Dr. Feingold had never met with them. Dr. Feingold provided pills to one patient in exchange for having the patient paint his house, even though the prescriptions had ostensibly been issued for the patient’s back pain. The record also indicates that Dr. Feingold continued to prescribe Schedule II narcotics even after Arizona had revoked the authority of natu-ropathic physicians like him to prescribe them.

Further, Dr. Feingold prescribed these substances in excess of the maximum dosages he recommended. In one case, in a single month he provided twenty-eight prescriptions to one patient, each for 120 pills — a total of more than 3,000 Oxyco-done and Oxycontin pills. In another case, he prescribed as many as 2,000 pills in a single month, despite the fact that the recommended maximum dosage would *1005 have allowed the consumption of only 186, to a patient who testified that he resold the pills to others. He liberally provided prescriptions for Hydrocodone, Percocet, Vicodin, Valium, Oxycontin, Oxycodone, and morphine, sometimes refilling these prescriptions at intervals of only two days, or even daily. Dr. Feingold also charged his patients by the number of prescriptions he wrote.

The evidence presented by Dr. Fein-gold’s “patients” also included the testimony of two undercover DEA agents who had obtained prescriptions for controlled substances both for themselves and for each other. Dr. Feingold issued prescriptions to one of these agents without examining her, and on one occasion, before he had even met her. At least one of these prescriptions was written for a Schedule II drug after Arizona had made it illegal for naturopathic physicians to dispense them. Finally, these agents testified that Dr. Feingold had advised them to refill their prescriptions at a particular pharmacy because certain other pharmacists had refused to fill his prescriptions.

In addition to this evidence, the government presented two expert witnesses — a naturopathic doctor named Dr. Thomas Kruzel, and a medical doctor named Dr. Michael Ferrante. Both experts testified about the standard of care with which medical professionals generally must comply, and both of them indicated that Dr. Feingold’s conduct fell far short of applicable professional standards. For instance, Dr. Kruzel testified that many of the prescriptions written by Dr. Feingold were “medically unnecessary” and that Dr. Feingold’s practice of prescribing narcotic drugs without conducting adequate physical examinations or taking his patients’ medical history was “highly unusual” and “outside the usual course of naturopathic medicine.” Likewise, Dr. Ferrante testified that Dr. Feingold’s prescription practices had failed to comply with generally observed professional guidelines, that Dr. Feingold had kept inadequate records, and that Dr. Feingold had prescribed unusually high and frequent doses of narcotic drugs. In addition, both experts consistently and unambiguously testified that Dr. Feingold’s conduct was outside the course of usual professional practice and that there was no legitimate medical purpose for the 185 prescriptions identified in the indictment.

In his defense, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Siao
Ninth Circuit, 2025
United States v. Enriquez
131 F.4th 940 (Ninth Circuit, 2025)
United States v. Nguyen
Ninth Circuit, 2024
United States v. Wilson
98 F.4th 1204 (Tenth Circuit, 2024)
Lopez v. United States
S.D. New York, 2023
United States v. David Read
Ninth Circuit, 2022
United States v. Simon
12 F.4th 1 (First Circuit, 2021)
United States v. Khan
989 F.3d 806 (Tenth Circuit, 2021)
United States v. Xiulu Ruan
966 F.3d 1101 (Eleventh Circuit, 2020)
Commonwealth v. Stirlacci
Massachusetts Supreme Judicial Court, 2020
Smith v. Super. Ct.
California Court of Appeal, 2018
United States v. Miller
891 F.3d 1220 (Tenth Circuit, 2018)
United States v. David Garrison
888 F.3d 1057 (Ninth Circuit, 2018)
United States v. Sabean
885 F.3d 27 (First Circuit, 2018)
United States v. Julio Diaz
Ninth Circuit, 2017

Cite This Page — Counsel Stack

Bluebook (online)
454 F.3d 1001, 2006 U.S. App. LEXIS 18319, 2006 WL 2035305, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-jeffrey-h-feingold-ca9-2006.